A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice

NCT06008691 · clinicaltrials.gov ↗

RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin Lymphoma, B-cell

Interventions

DRUG: "novel" MAB (alone or in combination)

Sponsor

Fondazione Italiana Linfomi - ETS

Collaborators

[object Object]